It’s Time to Rethink How Pharma Can Unleash the Potential of AI
The response to COVID-19 has brought into sharp focus the need for greater efficiencies in drug discovery and development. Artificial intelligence (AI) methods hold particular promise in helping to realise those efficiencies.